LUN.CO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Stats
Today's Volume	346 952
Average Volume	371 694
Market Cap	0.00
Last Dividend	DKK0 ( N/A )
Next Dividend	DKK0 ( N/A )
P/E	31.01
ATR14	DKK0 (0.00%)

H. Lundbeck A/S Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

H. Lundbeck A/S Financials

Annual	2021
Revenue:	DKK16.30B
Gross Profit:	DKK12.65B (77.62 %)
EPS:	DKK6.63

Q1	2022
Revenue:	DKK4.37B
Gross Profit:	DKK3.53B (80.67 %)
EPS:	DKK2.07

Q4	2021
Revenue:	DKK4.05B
Gross Profit:	DKK3.05B (75.33 %)
EPS:	DKK-0.0101

Q3	2021
Revenue:	DKK4.01B
Gross Profit:	DKK3.16B (78.79 %)
EPS:	DKK1.620

Financial Reports:

No articles found.

H. Lundbeck A/S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.